QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Interpretieren Sie somatische Varianten einfach und schnell mit HSMD

June 20, 2023 @ 10:00 am - 11:30 am

Verpassen Sie nicht die Gelegenheit, das bestgehütete Geheimnis von somatischen NGS-Tests kennenzulernen.
Die von QIAGEN entwickelte neue Datenbank namens HSMD enthält über 2 Jahrzehnte von Experten kuratierte Inhalte aus der QIAGEN Knowledge Base und Daten aus über 300.000 realen Onkologie-Fällen, um tiefgreifende Einblicke in die genaue Funktion und Handlungsfähigkeit von kleinen Varianten wie SNVs, Indels und Frameshifts zu bieten, die “klinisch beobachtet” oder aus wissenschaftlichen Publikationen kuratiert wurden.
Am 20. Juni werden unsere Experten Ihnen in einer Demonstation die neue Datenbank vorstellen und Ihnen ihre Funktionen, Fähigkeiten und Anwendungen vorstellen.
In diesem Webinar werden Sie lernen:
• Woher HSMD seine Daten zieht
• Wie Sie HSMD für verschiedene Anwendungen wie Forschung, molekulare Tests und pharmazeutische Entwicklung nutzen und anwenden können
• Wie Sie eine kostenlose, 5-tägige Testversion von HSMD für Ihr Labor erhalten können


Date: June 20, 2023
 10:00 am - 11:30 am
Register for event
Event Categories:
Event Tags:


Virtual – Germany
Register for event

On-demand Webinars

  • Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and tumor immune microenvironment (TME) for targeted therapy

    Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However, deeper molecular insights are needed to improve personalized treatment decisions that are tailored to specific molecular characteristics of a tumor. Integrating gene expression analysis in personalized oncology provides an add...

  • Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery

    In an era of near-limitless public experimental data but little standardization, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny.  In this webinar, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Kn...

  • Translating COSMIC's gold standard data into actionable insights

    As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, researchers, scientists, and clinicians need an accessible, streamlined and standardized way of keeping track of this potentially crucial, ever-growing body of actionable knowledge. Ove...

  • Target exploration and cell line selection for drug discovery

    Cancer cell line models have been a cornerstone of cancer research for decades. Cancer cell lines profiling can be a powerful tool for the identification of genes’ alterations or pathways cancer-related and for the discovery of putative drug targets. This webinar will focus using Qiagen OmicSoft Lands and Ingenuity Pathway Analysis as guides for the selection of cel...

  • How to perform DNA-seq and resequencing data analyses using QIAGEN CLC Genomics Workbench

    In this webinar, we’ll introduce algorithms required to perform data analysis for resequencing next-generation sequencing data. Together, we’ll explore:  • Read mapper • Variant callers • Annotations and filters • Genome Browser  Bring any questions you may have, and we will answer them during the webinar. ...

  • One tool to help biopharma accelerate cancer drug discovery and repurposing: A translational research use-case and discussion

    The development of new cancer drugs is challenging, costly, and time-consuming. As translational research on cancer diagnostics and genomic profiling rapidly evolves, the ability to confidently and efficiently identify specific oncogenes and tumor suppressors involved in oncogenesis is becoming increasingly difficult. This brief half-hour webinar is intended for bi...